Earnings Beats

Earnings Beats Recent News

Cheesecake Factory Q1 Earnings Beat Estimates, Rise Y/Y
The Cheesecake Factory Incorporated (NASDAQ: CAKE) reported impressive first-quarter fiscal 2024 results, with earnings and revenues beating the Zacks Consensus Estimate. The top and the bottom line increased from the prior-year quarter's figure.
Groupon Beats Q1 Earnings and Revenue Estimates
Groupon (NASDAQ: GRPN) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of a loss of $0.18 per share. This compares to loss of $0.65 per share a year ago. These figures are adjusted for non-recurring items.
Kronos Worldwide Q1 Earnings and Revenues Beat Estimates
Kronos Worldwide (NYSE: KRO) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to loss of $0.13 per share a year ago. These figures are adjusted for non-recurring items.
Nutrien Beats Q1 Earnings and Revenue Estimates
Nutrien (NYSE: NTR) came out with quarterly earnings of $0.46 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $1.11 per share a year ago. These figures are adjusted for non-recurring items.
Vital Farms Surpasses Q1 Earnings and Revenue Estimates
Vital Farms (NASDAQ: VITL) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.16 per share a year ago. These figures are adjusted for non-recurring items.
Royalty Pharma Beats Q1 Earnings and Revenue Estimates
Royalty Pharma (NASDAQ: RPRX) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.96 per share. This compares to earnings of $1.60 per share a year ago. These figures are adjusted for non-recurring items.
Perrigo Q1 Earnings Surpass, Sales Miss Estimates
Perrigo Company plc (NYSE: PRGO) reported adjusted earnings of 29 cents per share in the first quarter of 2024, beating the Zacks Consensus Estimate of 24 cents. Earnings were down 35.6% year over year, primarily due to a negative financial impact of 30 cents per share from infant formula.
EverQuote Q1 Earnings Top Estimates, Revenues Fall Y/Y
EverQuote (NASDAQ: EVER) delivered first-quarter 2024 earnings per share of 5 cents in contrast to the Zacks Consensus Estimate of a loss of 7 cents as well as the year-ago quarter's loss of 8 cents per share.
Why Itron Might be Well Poised for a Surge
Itron (NASDAQ: ITRI) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with analysts still raising their earnings estimates for the company.
Valvoline Surpasses Q2 Earnings and Revenue Estimates
Valvoline (NYSE: VVV) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.23 per share a year ago. These figures are adjusted for non-recurring items.
Fidelity National's Shares Up 5.5% Since Q1 Earnings Beat
Fidelity National Information Services, Inc. (NYSE: FIS) shares gained 5.5% since it reported first-quarter 2024 results on May 6, 2024. Upward revision in adjusted earnings per share guidance, along with favorable EBITDA margin expansion, might have buoyed investor confidence in the stock.
Inspire Medical Q1 Earnings Beat, Gross Margin Up
Inspire Medical Systems, Inc. (NYSE: INSP) delivered a loss per share of 34 cents in first-quarter 2024, narrower than the year-ago period's loss of 53 cents per share. The metric was also narrower than the Zacks Consensus Estimate of a loss of 63 cents per share.
Reddit Users See An 'Inverse Moment' As Shares Pop 14% On Social Media Platform's Financial Performance
Reddit beat expectations, with revenue of $243 million; ad revenue was up 39%. Analysts are optimistic about its potential for profitability.

Explore Benzinga's Financial Tools

Find Stocks Tailored to Your Trading Interests
Find Stocks Tailored to Your Trading Interests
Benzinga Pro offers a real-time newsfeed as headlines break on earnings releases, analyst ratings, rumors, the biggest movers, and many more actionable alerts.

Compare Benzinga's Favorite Stock Brokers

Claim Exclusive Offers

Compare Benzinga's Favorite Cryptocurrency Brokers

Claim Exclusive Offers